Titan Biotech Ltd — Important, 30-05-2026: Company Update

Titan Biotech's Board has approved the re-appointment of M/s Sanjay Kumar Garg & Associates as the company's Cost Auditor for the fiscal year 2026-2027. This decision was made following the Audit Committee's assessment and requires ratification by shareholders at the forthcoming Annual General Meeting. This ensures continued independent and expert review of the company's cost structures, maintaining strong financial transparency and compliance with reporting standards. It’s a routine but important step for robust corporate governance and investor confidence.